Zeria Obtains Japanese Rights To U.S. Hemcon Products
This article was originally published in PharmAsia News
Executive Summary
Zeria Pharmaceutical April 8 signed a licensing agreement for exclusive rights to develop and market products from Portland, Oregon-based Hemcon in Japan